Welcome to our dedicated page for China Jo-Jo Drugstores news (Ticker: CJJD), a resource for investors and traders seeking the latest updates and insights on China Jo-Jo Drugstores stock.
China Jo-Jo Drugstores, Inc. (CJJD) is described in its public communications as an online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services in China. The CJJD news page on Stock Titan aggregates company-specific announcements, market disclosures and other coverage related to this pharmacies and drug stores issuer.
Recent news releases highlight several themes in CJJD’s developments. The company has reported fiscal year 2024 financial results, with revenue reported across retail drugstores, online pharmacy and wholesale segments. It has discussed changes in segment performance, gross margin, operating expenses and net loss, as well as its use of modern wholesale platforms to reach buyers in the pharmaceutical distribution market.
CJJD’s news flow also includes capital markets activity, such as multiple registered direct offerings of ordinary shares under an effective shelf registration statement on Form F-3. These announcements describe the size of each offering, the purchase price per share and the company’s stated intention to use net proceeds for general corporate purposes and working capital.
Another recurring topic is CJJD’s Nasdaq listing status. The company has issued press releases about receiving extensions from Nasdaq to meet the minimum bid price requirement, implementing a 1-for-20 reverse stock split of its ordinary shares and later regaining compliance with Nasdaq’s minimum bid price rule.
More recently, CJJD announced definitive agreements for a strategic restructuring to transition toward an asset-light, wholesale-focused model. This includes a planned acquisition of Allright (Hangzhou) Internet Technology Co. Ltd., which is engaged in pharmaceutical wholesale, and a planned sale of CJJD’s drug retail business to certain existing shareholders and their affiliates, subject to shareholder approval and other conditions.
Investors and observers using the CJJD news page can review these types of updates in one place, including earnings announcements, financing transactions, listing compliance notices and strategic restructuring plans, to better understand how the company describes its operations and corporate actions over time.
China Jo-Jo Drugstores (CJJD) announced a 1-for-12 reverse stock split effective April 7, 2022. This means every 12 existing shares will convert to 1 share, affecting all shareholders uniformly. Fractional shares will round up to the nearest whole share. This decision was approved by the board and shareholders, aiming to enhance the stock's marketability and comply with listing requirements on the Nasdaq Capital Market. The new CUSIP number will be G2124G 112.
China Jo-Jo Drugstores (NASDAQ: CJJD) received a 180-day extension from Nasdaq to meet the $1.00 minimum bid price requirement, now until July 25, 2022. The company must close at or above this price for 10 consecutive trading days to regain compliance. This follows a prior notification on July 26, 2021, about failing to maintain the required minimum bid price over 30 trading days.
China Jo-Jo Drugstores (CJJD) reported impressive financial results for the first half of fiscal 2022, ending September 30, 2021. Revenue surged by 26.8% to $78.48 million, driven by robust growth in online pharmacy (33.5%) and wholesale segments (63.6%). The Company notably narrowed its net loss by 86% to $0.27 million, with loss per share improving to $0.01. Despite challenges from COVID-19, CJJD's effective operations and expanding market presence are noteworthy. The Company also received accolades for its ESG initiatives, supporting social and environmental progress.
China Jo-Jo Drugstores has been awarded the Government Quality Award by the Gongshu District government in Hangzhou, recognizing its excellence in quality management and social responsibility. The honor is based on rigorous evaluations, including customer satisfaction surveys. The company has emphasized its commitment to quality, implementing over 100 standard-related documents and aiming to transition from price competition to quality and brand competition. Chairman Lei Liu expressed pride in the award and affirmed the company's dedication to community welfare and public health initiatives during the COVID-19 pandemic.
Summary not available.
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) has successfully completed its Redomiciliation Merger, converting each outstanding share of its common stock into an ordinary share of China Jo-Jo Drugstores, Inc., now registered in the Cayman Islands. This move maintains its NASDAQ trading symbol, CJJD, while facilitating potential business growth and operational flexibility in an international context. Jo-Jo Drugstores is a leading retailer and wholesaler of pharmaceutical and healthcare products in China, operating both online and offline.
China Jo-Jo Drugstores (CJJD) has announced that its Daguan store has been designated as one of the first four-star livelihood pharmaceutical service stations in Hangzhou. This recognition highlights the store's ability to provide at least 15 types of pharmaceutical services. The local government aims to establish a total of 43 such stations in Hangzhou and 300 across Zhejiang Province this year. CEO Lei Liu stated this achievement reflects the company's commitment to high-quality public service and plans to expand its service reach and offerings in the region.
China Jo-Jo Drugstores (CJJD) reported its fiscal year 2021 results, achieving $133.13 million in revenue, a 13.5% increase from the prior year. Gross profit rose 14.6% to $29.24 million, with a gross margin improvement to 22.0%. The online pharmacy segment saw significant growth, up 66.1% to $22.48 million. Despite these gains, the company recorded a net loss of $8.38 million, compared to $6.46 million the previous year. Cash reserves increased to $22.05 million, reflecting better financial condition.
China Jo-Jo Drugstores, a prominent healthcare retailer in China, hosted a reception for provincial government officials on April 26, 2021. The visit highlighted the company's smart medicine machines, which facilitate 24-hour self-service drug purchases. The company has also expanded its delivery services to remote areas, establishing 40 service stations since May 2019. Chairman Lei Liu emphasized commitment to government initiatives and the goal of supporting “Healthy China 2030”. Jo-Jo Drugstores aims to meet diverse health needs and enhance public service as a trusted healthcare provider.
China Jo-Jo Drugstores (NASDAQ: CJJD) reported third fiscal quarter results for the period ending December 31, 2020, revealing a 6.5% revenue increase to $35.54 million and a 11.0% gross profit rise to $8.09 million. However, the company faced a net loss of $6.29 million, contrasting with a profit of $0.46 million in the previous year. Key growth was seen in the online pharmacy sector, which surged 66.4% year-over-year, driven by enhanced digital services and customer engagement strategies. Despite positive revenue growth, increased operational losses and expenses raise concerns about profitability sustainability.